Earkart Limited (BSE: 544549) is a Noida, Uttar Pradesh-based company in the Medical Testing, Analyzing, and Diagnostic Equipment industry. With a market capitalisation of ₹0 Cr, it ranks #5,235 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 7 in Medical Testing, Analyzing, and Diagnostic Equipment. At ₹111.00 (as of 10 Nov 2026), the share price is 51.9% below its 52-week high of ₹231.00 and 6.4% above its 52-week low of ₹104.35. The share price is down 53.1% over one year and down 20.7% over three months.
| Current Price | ₹111.00 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 544549 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment |
| P/E Ratio | 29.1 |
| Return on Assets | 9.77% |
| 52-Week Range | ₹104.35 – ₹231.00 |
| 1-Year Price Change | -53.1% |
| 3-Month Price Change | -20.7% |
| Beta (1Y) | 0.24 |
| Headquarters | Noida, Uttar Pradesh |
| Website | www.earkart.in |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| EPS (Basic) | ₹0.00 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Delivery averaged 85.2% of traded volume across 7 BSE sessions (16 Oct 2026 – 6 Nov 2026).
Earkart Limited manufactures and distributes modern hearing aids and related accessories in India and internationally. The company offers adjustable foldable walkers; Multi Sensory Inclusive Educational (MSIED) Kit designed for educational purpose for mentally retarded children; Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged; and other rehabilitation products, including their components, accessories, and parts. It also provides hearing aid test systems; BTE kit component; and zinc air battery. Additionally, the company offers after-sales services; user training; and research and development of hearing aids. Earkart Limited was incorporated in 2021 and is based in Noida, India.
1. Surgical & Medical Equipment-This segment manufactures and distributes hearing aids and related accessories. 2. NA-NA 3. NA-NA 4. NA-NA
1. Surgical & Medical Equipment-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Molbio Diagnostics Limited | ₹15,144 Cr | 89 | — | ₹259 Cr | — |
| Hemant Surgical Industries Lim | ₹850 Cr | 39.1 | — | — | +120.8% |
| Credent Connect N Care | ₹728 Cr | 28.6 | — | — | — |
| QMS Medical Allied Services Limited | ₹333 Cr | 31.9 | 12.29% | ₹57 Cr | +76.8% |
| Nureca Ltd | ₹285 Cr | 141.5 | 1.11% | ₹59 Cr | +18.2% |
| Avience Biomedicals Limited | ₹134 Cr | 11.3 | 27.86% | — | — |
| Earkart Limited | ₹0 Cr | 29.1 | — | ₹0 Cr | -53.1% |
Listed by market capitalisation. Ratios are shown for context only.
Earkart Limited is trading at ₹111.00, with a market capitalisation of ₹0 Cr.
Earkart Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment).
Earkart Limited has a P/E of 29.1.
Earkart Limited is listed on the BSE under the scrip code 544549.
Earkart Limited's share price is down 53.1% over one year and down 20.7% over three months. Its 52-week range is ₹104.35 to ₹231.00.
In Q2 FY26, Earkart Limited reported revenue of ₹0 Cr and net profit of ₹0 Cr, with basic EPS of ₹0 (standalone, parsed from the company's exchange filing).
Data as of 10 Nov 2026. Descriptive market data only — not investment advice.